Home> Products> urea ip

{ "products": [ { "_id": "67e298ff84075b7fd68a27f7", "fptag": "STERISHEALTHCAREPVTLTDD1C2", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIEMPAFLOZIN SITA 25/100", "description": "GLIEMPAFLOZIN SITA 25/100 is an advanced anti-diabetic medication containing Empagliflozin (25mg) and Sitagliptin (100mg), formulated to effectively control blood sugar levels in individuals with Type 2 Diabetes Mellitus. This powerful combination helps regulate glucose levels, improve insulin function, and reduce the risk of diabetes-related complications. It is designed for patients requiring dual therapy to achieve better glycemic control.\n\n \nKey Benefits:\n \n\nEffective Blood Sugar Control – Lowers HbA1c levels and maintains long-term glycemic stability.\nPromotes Weight Loss – Empagliflozin helps in reducing excess body weight by eliminating excess glucose.\nHeart & Kidney Protection – Reduces the risk of cardiovascular diseases and kidney complications.\nEnhanced Insulin Sensitivity – Improves insulin response and minimizes glucose spikes.\nConvenient Dual Therapy – Combines two powerful anti-diabetic agents in one tablet for better diabetes management.\n\n \nHow Does It Work?\n \n\nEmpagliflozin blocks the SGLT2 protein in the kidneys, preventing glucose reabsorption and promoting glucose excretion through urine. This helps lower blood sugar levels naturally while supporting heart and kidney health.\n\nSitagliptin works by inhibiting the DPP-4 enzyme, which increases the levels of incretin hormones that stimulate insulin release and reduce glucose production in the liver.\n\nTogether, they offer comprehensive diabetes control by lowering blood sugar through different mechanisms, making it a superior option for Type 2 Diabetes management.\n\n \nDirections for Use:\n \n\nTake GLIEMPAFLOZIN SITA 25/100 as prescribed by your doctor.\n\nSwallow the tablet whole with water, preferably once daily with or without food.\n\nMaintain a healthy diet and regular exercise for best results.\n\nDo not exceed the recommended dosage without consulting a healthcare professional.\n\n \nSide Effects:\n \n\nWhile generally well-tolerated, some users may experience:\n\nFrequent Urination (due to glucose excretion)\nDehydration & Dizziness\nMild Nausea or Stomach Discomfort\nHypoglycemia (Low Blood Sugar) – Especially if combined with insulin or sulfonylureas\nUrinary or Genital Infections (due to increased sugar excretion in urine)\n\nSeek medical attention if you experience severe allergic reactions, persistent dizziness, or signs of dehydration.", "price": 425.0, "discountamount": 128.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "sulfonylureas urinary", "generally welltolerated", "recommended dosage", "regular exercise", "healthy diet", "food maintain", "water preferably", "doctor swallow", "gliempaflozin sita 25100", "superior option", "mechanisms making", "incretin hormones", "dpp4 enzyme", "supporting heart", "sglt2 protein", "diabetes management", "cardiovascular diseases", "diabetesrelated complications", "empagliflozin 25mg", "reduce glucose production", "stimulate insulin release", "work empagliflozin blocks", "increased sugar excretion", "genital infections due", "lowering blood sugar", "promoting glucose excretion", "powerful antidiabetic agents", "sitagliptin 100mg formulated", "advanced antidiabetic medication" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1316, "imageuri": "https://bizimages.withfloats.com/actual/5eea78523d4740a092e22644d2f108be.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/5eea78523d4740a092e22644d2f108be.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-03-25T11:52:31.562Z", "updatedon": "2025-03-25T11:53:30.184Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/indore/medicines/gliempaflozin-sita-25-100/1316", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empagliflozin 25mg, Sitagliptin 100mg", "category": "Diabetic Range", "tags": [ "Empagliflozin 25mg,", "Sitagliptin 100mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 12.0, "isnotforsale": false }, { "_id": "67bd9a2eec08031bcbf3cfc0", "fptag": "STERISHEALTHCAREPVTLTDD1C2", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Steriphyllin SR 200", "description": "Steriphyllin SR 200 is a sustained-release formulation of Acebrophylline 200 mg, a medication primarily used to manage respiratory conditions like asthma, chronic obstructive pulmonary disease (COPD), and other bronchial disorders. This medication provides long-lasting relief from symptoms such as wheezing, breathlessness, and cough by relaxing the muscles in the airways, allowing for easier breathing. Its sustained-release (SR) formulation ensures that the active ingredient is gradually released into the bloodstream over time, making it effective for long-term control of respiratory symptoms. Steriphyllin SR 200 is an ideal choice for patients requiring regular treatment for chronic respiratory conditions, offering both bronchodilatory and anti-inflammatory effects to help improve quality of life.\n\n \n\nKey Benefits:\n \n\nRelieves Symptoms of Asthma and COPD:\nAcebrophylline helps to relax the bronchial muscles and open up the airways, reducing wheezing, cough, and breathlessness associated with asthma and COPD.\n\nSustained Action:\nThe sustained-release formulation provides long-lasting effects, offering convenient once-daily dosing, ensuring continuous relief from symptoms throughout the day.\n\nImproves Breathing:\nBy dilating the bronchi and reducing inflammation, it enhances lung function, making breathing easier and improving overall respiratory health.\n\nReduces Excess Mucus:\nAcebrophylline’s mucolytic properties help break down and thin the mucus in the airways, making it easier to clear the air passages and improve airflow.\n\nFewer Side Effects Due to Slow Release:\nThe SR (sustained-release) formulation minimizes the peak concentration of the drug in the bloodstream, reducing the likelihood of side effects and providing smoother, prolonged action.\n\n \n\nHow Does It Work?\n \n\nSteriphyllin SR 200 works through its active ingredient, Acebrophylline, which combines two key actions:\n\nBronchodilation:\nAcebrophylline works by relaxing the smooth muscles in the bronchial walls, which helps in opening the airways. This reduces airway resistance, allowing for improved airflow and easier breathing.\n\nAnti-inflammatory Action:\nAcebrophylline also has anti-inflammatory properties, reducing the swelling and irritation in the airways. By decreasing inflammation, it helps to prevent bronchoconstriction and reduces symptoms like wheezing and tightness in the chest.\n\nMucolytic Effect:\nAcebrophylline helps to break down and thin the mucus lining the airways, making it easier to clear and improving the overall airflow. This helps in conditions where excess mucus production is a problem, such as in COPD or chronic bronchitis.\n\nThe sustained-release mechanism ensures that the medication is released slowly into the bloodstream over time, providing long-lasting effects with once-daily dosing.\n\n \n\nSide Effects:\n \n\nWhile Steriphyllin SR 200 is generally well-tolerated, some individuals may experience mild side effects, which may include:\n\nGastrointestinal Distress:\nNausea, vomiting, stomach pain, or indigestion may occur, especially when the medication is taken on an empty stomach.\n\nHeadache:\nSome patients may experience headaches, which are usually mild and temporary.\n\nDizziness or Lightheadedness:\nA slight feeling of dizziness may occur, especially when standing up quickly. This is usually temporary.\n\nPalpitations or Increased Heart Rate:\nIn some cases, Acebrophylline may cause palpitations or a slight increase in heart rate due to its bronchodilator action.\n\nRash or Allergic Reactions:\nAlthough rare, some individuals may experience skin rashes, itching, or other allergic reactions. If any severe reactions occur, seek immediate medical attention.\n\nTremors or Nervousness:\nSome users may experience mild tremors or feelings of nervousness, especially at higher doses.\n\nSleep Disturbances:\nIn rare cases, the medication may affect sleep, causing insomnia or vivid dreams.", "price": 164.0, "discountamount": 50.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "wheezing breathlessness", "medication primarily", "reduces symptoms", "rare cases", "temporary palpitations", "temporary dizziness", "improved airflow", "airways making", "airways allowing", "smooth muscles", "bloodstream reducing", "bronchial muscles", "easier breathing", "vivid dreams", "allergic reactions", "slight increase", "slight feeling", "generally welltolerated", "steriphyllin sr 200", "released slowly", "chronic bronchitis", "mucus lining", "prevent bronchoconstriction", "decreasing inflammation", "bronchial walls", "side effects", "peak concentration", "slow release", "air passages", "improve quality", "ideal choice", "longterm control", "time making", "gradually released", "longlasting relief", "bronchial disorders", "reducing inflammation", "sustainedrelease formulation", "cases acebrophylline", "experience headaches", "antiinflammatory effects", "acebrophylline 200 mg", "active ingredient", "copd acebrophylline helps", "experience mild tremors", "active ingredient acebrophylline", "antiinflammatory properties reducing", "excess mucus production", "manage respiratory conditions", "sustainedrelease mechanism ensures", "copd sustained action", "day improves breathing", "medical attention tremors", "bronchodilator action rash", "heart rate due", "increased heart rate", "empty stomach headache" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1302, "imageuri": "https://bizimages.withfloats.com/actual/8f8d5f2dc957416db474e63954ddc9c3.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/8f8d5f2dc957416db474e63954ddc9c3.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-25T10:23:42.56Z", "updatedon": "2025-02-25T10:24:27.595Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/indore/medicines/steriphyllin-sr-200/1302", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Acebrophylline 200mg", "category": "Asthma Range ", "tags": [ "Acebrophylline SR Tablet 200 mg uses", "Acebrophylline SR 200mg", "Acebrophylline SR Tablet 200 Mg Uses in Hindi", "Acebrophylline 200 mg dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 12.0, "isnotforsale": false }, { "_id": "67a206d2925cc328fe1f9cc5", "fptag": "STERISHEALTHCAREPVTLTDD1C2", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIEMPAFLOZIN LINA 10MG/ 5MG ", "description": "GLIEMPAFLOZIN LINA is an advanced oral antidiabetic medication that combines Empagliflozin (10 mg) and Linagliptin (5 mg) to effectively manage Type 2 Diabetes Mellitus (T2DM). This combination helps regulate blood sugar levels while offering cardiovascular and renal benefits. It is a dual-action therapy that enhances insulin secretion and promotes glucose excretion, making it an excellent choice for diabetes control.\n\n \nKey Benefits:\n \n\nEffective Blood Sugar Control: Helps lower and maintain optimal blood glucose levels in patients with Type 2 Diabetes.\nDual Mechanism Action: Targets different pathways to improve insulin response and reduce glucose reabsorption.\nWeight Management Support: May aid in weight loss by eliminating excess glucose from the body.\nHeart and Kidney Protection: Reduces cardiovascular risks and provides potential renal protection for diabetic patients.\nConvenient Dosing: Single-tablet formulation for ease of administration and better patient adherence.\n \nHow Does It Work?\n \n\nGLIEMPAFLOZIN LINA works through a dual mechanism:\nEmpagliflozin blocks the SGLT2 transporter in the kidneys, preventing glucose reabsorption and increasing its elimination through urine. This helps lower blood sugar levels and reduces the risk of cardiovascular complications.\n\nLinagliptin inhibits DPP-4 enzyme activity, thereby increasing incretin hormone levels. This leads to increased insulin secretion and decreased glucagon production, ensuring better glucose metabolism.\n\n \nDirections for Use:\n \n\nTake one tablet daily or as prescribed by your healthcare provider.\n\nCan be taken with or without food.\n\nMaintain a healthy diet and regular exercise routine for optimal results.\n\nDo not crush, chew, or break the tablet; swallow it whole with water.\n\n \nSide Effects:\n \n\nWhile GLIEMPAFLOZIN LINA is well-tolerated, some individuals may experience:\n\nFrequent urination due to increased glucose excretion.\n\nMild dehydration or increased thirst.\n\nHypoglycemia (low blood sugar), especially when combined with insulin or sulfonylureas.\n\nUrinary tract infections (UTIs) or genital yeast infections.\n\nAllergic reactions, such as rash or itching (rare).\n\nDigestive discomfort, including nausea or diarrhea.", "price": 315.0, "discountamount": 95.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "gliempaflozin lina", "tablet swallow", "crush chew", "optimal results", "healthy diet", "food maintain", "healthcare provider", "tablet daily", "sglt2 transporter", "patient adherence", "body heart", "weight loss", "excellent choice", "dualaction therapy", "offering cardiovascular", "linagliptin 5 mg", "renal benefits", "increased insulin secretion", "potential renal protection", "improve insulin response", "enhances insulin secretion", "water side effects", "regular exercise routine", "glucose metabolism directions", "eliminating excess glucose" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1283, "imageuri": "https://bizimages.withfloats.com/actual/235e78d4dda64c329b53c38b0502462f.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/235e78d4dda64c329b53c38b0502462f.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-02-04T12:23:45.388Z", "updatedon": "2025-03-17T06:30:16.59Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/indore/medicines/gliempaflozin-lina-10mg-5mg-/1283", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empagliflozin 10 mg, Linagliptin5 mg", "category": "Diabetic Range", "tags": [ "empagliflozin-linagliptin 25-5 mg", "Empagliflozin/linagliptin side effects", "Linagliptin empagliflozin combination brand name", "empagliflozin-linagliptin 25-5 mg price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 12.0, "isnotforsale": false }, { "_id": "67519f23130d6da90b270f18", "fptag": "STERISHEALTHCAREPVTLTDD1C2", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LINALIGLIP DAPAMET ", "description": "LINALIGLIP DAPAMET is a potent combination therapy designed to manage type 2 diabetes effectively. With a synergistic blend of Linagliptin (5mg), Dapagliflozin (10mg), and Metformin Hydrochloride (SR) (1000mg), this medication helps regulate blood sugar levels while addressing multiple aspects of diabetes care. It is a comprehensive solution that enhances glycemic control, reduces insulin resistance, and minimizes the risk of complications associated with diabetes.\n\n \nKey Benefits:\n \n\nComprehensive Glycemic Control\n\nThe triple-action formula targets different pathways to maintain optimal blood sugar levels throughout the day.\nWeight Management\n\nDapagliflozin helps reduce excess body weight, a common issue in people with type 2 diabetes.\nCardiovascular Benefits\n\nProven to lower the risk of cardiovascular events, such as heart attack and stroke, in diabetic patients.\nEnhanced Insulin Sensitivity\n\nMetformin improves the body's response to insulin, reducing insulin resistance.\nConvenience\n\nCombines three powerful diabetes medications into one tablet, reducing the need for multiple prescriptions and enhancing patient compliance.\n \nHow Does It Work?\n \n\nLINALIGLIP DAPAMET works through a multi-pronged approach to diabetes management:\n\nLinagliptin: Inhibits the DPP-4 enzyme, allowing incretin hormones to stimulate insulin release and reduce glucagon levels, thereby lowering blood sugar levels.\nDapagliflozin: Inhibits SGLT2 in the kidneys, promoting glucose excretion through urine, which helps in both glycemic control and weight loss.\nMetformin (SR): Reduces glucose production in the liver and improves insulin sensitivity, ensuring effective utilization of glucose by the body.\nThis powerful combination ensures steady blood sugar control while addressing associated complications.\n\n \nDirections for Use:\n \n\nDosage\n\nTake as prescribed by your healthcare provider. Typically, it is taken once daily with meals to minimize gastrointestinal discomfort.\nAdministration\n\nSwallow the tablet whole with a glass of water. Do not crush, chew, or break it.\nConsistency\n\nUse the medication regularly at the same time each day for optimal results.\nLifestyle Integration\n\nCombine the medication with a balanced diet, regular exercise, and routine blood sugar monitoring for the best outcomes.\n \nSide Effects:\n \n\nWhile LINALIGLIP DAPAMET is generally well-tolerated, some individuals may experience:\n\nCommon Side Effects:\n\nNausea\nDiarrhea\nMild urinary tract infections\nHeadache\nRare Side Effects:\n\nLow blood sugar (hypoglycemia) when combined with insulin or sulfonylureas\nIncreased urination\nAllergic reactions such as rash or swelling\nIf you experience severe side effects or symptoms like persistent stomach pain, difficulty breathing, or signs of infection, seek immediate medical attention.", "price": 232.0, "discountamount": 70.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "medication regularly", "complications directions", "tablet reducing", "medical attention", "infection seek", "generally welltolerated", "linaliglip dapamet", "crush chew", "glycemic control", "multipronged approach", "bodys response", "heart attack", "cardiovascular events", "common issue", "comprehensive solution", "synergistic blend", "multiple prescriptions", "diabetes care", "addressing multiple aspects", "stimulate insulin release", "powerful diabetes medications", "outcomes side effects", "healthcare provider typically", "reduce glucagon levels", "enhancing patient compliance", "tripleaction formula targets" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1248, "imageuri": "https://bizimages.withfloats.com/actual/4bae014fb4964741b1aaada226c4128f.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/4bae014fb4964741b1aaada226c4128f.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-12-05T12:40:00.332Z", "updatedon": "2024-12-05T12:42:37.221Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/indore/medicines/linaliglip-dapamet-/1248", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Linagliptin (5mg), Dapagliflozin(10mg) and Metformin Hydrochloride (SR) (1000mg)", "category": "Diabetic Range", "tags": [ "Dapagliflozin and Linagliptin combination brand name", "Linagliptin and Dapagliflozin side effects", "Linagliptin Dapagliflozin brands in India", "Dapagliflozin and Linagliptin tablets uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 12.0, "isnotforsale": false }, { "_id": "668bdbe9cce8091ad8a02659", "fptag": "STERISHEALTHCAREPVTLTDD1C2", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "DIOWELPREX 250 ORAL SOLUTION ", "description": "DIOWELPREX 250 ORAL SOLUTION \nDivalproex (250mg/5ml)\nOverview\nDIOWELPREX 250 ORAL SOLUTION contains 250 milligrams of Divalproex Sodium per 5 milliliters (ml). This medication is used to treat various conditions, including epilepsy, bipolar disorder, and migraines. Divalproex Sodium, also known as valproate semisodium, is an anticonvulsant and mood stabilizer that helps to control seizures, stabilize mood swings, and prevent migraine headaches.\n\nUses\nEpilepsy: DIOWELPREX 250 ORAL SOLUTION is used to treat seizure disorders. It helps in managing different types of seizures, including absence seizures, complex partial seizures, and multiple seizure types.\nBipolar Disorder: This medication is effective in treating the manic episodes associated with bipolar disorder. It helps stabilize mood and reduce the frequency and severity of mood swings.\nMigraine Prophylaxis: DIOWELPREX 250 is also used to prevent migraine headaches. It reduces the number of migraine attacks and their intensity.\nDosage and Administration\nIndividualized Treatment: The dosage is individualized based on the patient's age, weight, medical condition, and response to treatment. It is crucial to follow the healthcare provider's instructions carefully.\nTypical Dosage: For epilepsy, the initial dosage is often 10-15 mg/kg/day, which may be increased gradually. For bipolar disorder, the starting dose is typically 750 mg/day, which can be adjusted based on response. For migraine prevention, the usual dose is 250 mg twice daily.\nAdministration: Shake the bottle well before each use. Measure the prescribed amount using the provided measuring device. DIOWELPREX 250 ORAL SOLUTION can be taken with or without food, but taking it with food can help reduce stomach upset.\nMechanism of Action\nDivalproex Sodium increases the levels of gamma-aminobutyric acid (GABA) in the brain. GABA is a neurotransmitter that helps calm neuronal activity. By enhancing GABA levels, Divalproex reduces the excitability of neurons, helping to control seizures, stabilize mood, and prevent migraines.\n\nSide Effects\nCommon Side Effects: These may include nausea, vomiting, dizziness, drowsiness, diarrhea, weight gain, hair loss, and tremors. These side effects are usually mild and tend to diminish with continued use.\nSerious Side Effects: Rare but serious side effects include liver problems, pancreatitis, blood disorders, severe abdominal pain, severe drowsiness, and unusual bleeding or bruising. Seek immediate medical attention if these symptoms occur.\nAllergic Reactions: Symptoms may include rash, itching, swelling, and difficulty breathing. Discontinue use and seek medical attention if these symptoms develop.\nPrecautions\nMedical History: Inform your healthcare provider about your complete medical history, particularly if you have liver disease, pancreatitis, urea cycle disorders, or a family history of these conditions.\nPregnancy and Breastfeeding: Divalproex can cause harm to an unborn baby and should not be used during pregnancy unless absolutely necessary. It also passes into breast milk, so consult your healthcare provider before use if you are breastfeeding.\nDrug Interactions: Divalproex may interact with other medications, including other anticonvulsants, blood thinners, and certain antibiotics. Always inform your healthcare provider about all the medications and supplements you are taking to avoid adverse interactions.\nMonitoring\nRegular monitoring of liver function, blood cell counts, and valproate levels in the blood is recommended to ensure the safe and effective use of DIOWELPREX 250. Regular follow-up with your healthcare provider is essential to adjust the dosage and monitor for potential side effects.\n\nConclusion\nDIOWELPREX 250 ORAL SOLUTION, containing 250 mg of Divalproex Sodium per 5 ml, is a versatile medication for managing epilepsy, bipolar disorder, and migraines. Its ability to stabilize neuronal activity makes it an effective choice for controlling seizures, stabilizing mood, and preventing migraines. Proper adherence to the prescribed dosage, regular monitoring, and consulting your healthcare provider for personalized advice are essential for achieving optimal therapeutic outcomes with DIOWELPREX 250.\n For further information \n Email: info@sterispharma.com / contact@sterispharma.com\n Call/WhatsApp: 7877551268, 7849827488\n BUY NOW\n", "price": 445.0, "discountamount": 134.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "250 mg", "750 mg", "10-15 mg", "hair loss", "usual dose", "GABA levels", "weight gain", "mood swings", "breast milk", "unborn baby", "5 milliliters", "effective use", "continued use", "liver disease", "stomach upset", "starting dose", "250 milligrams", "initial dosage", "Typical Dosage", "liver function", "blood thinners", "liver problems", "manic episodes", "family history", "mood stabilizer", "blood disorders", "different types", "absence seizures", "valproate levels", "Proper adherence", "effective choice", "unusual bleeding", "measuring device", "migraine attacks", "bipolar disorder", "other medications", "Divalproex Sodium", "Regular follow-up", "Drug Interactions", "severe drowsiness", "neuronal activity", "medical condition", "seizure disorders", "blood cell counts", "various conditions", "Regular monitoring", "Allergic Reactions", "migraine headaches", "personalized advice", "migraine prevention", "healthcare provider", "Common Side Effects", "versatile medication", "adverse interactions", "Migraine Prophylaxis", "valproate semisodium", "Serious Side Effects", "urea cycle disorders", "other anticonvulsants", "severe abdominal pain", "multiple seizure types", "potential side effects", "gamma-aminobutyric acid", "Individualized Treatment", "complex partial seizures", "complete medical history", "immediate medical attention", "DIOWELPREX 250 ORAL SOLUTION", "optimal therapeutic outcomes" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1021, "imageuri": "https://bizimages.withfloats.com/actual/d58acc91bb9d4149a0a6a47ee30c0183.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/d58acc91bb9d4149a0a6a47ee30c0183.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-08T12:30:33.607Z", "updatedon": "2024-07-08T12:30:33.607Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/indore/medicines/diowelprex-250-oral-solution-/1021", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Divalproex (250mg/5ml)", "category": "Neurology Range", "tags": [ "Divalproex 250 mg", "Divalproex prolonged release tablets uses", "Divalproex extended release tablets IP 250 mg", "Divalproex side effects", "Divalproex 250 mg Uses in Hindi", "Divalproex syrup", "divalproex extended-release 250 mg reviews", "Divalproex 250 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 0.0, "isnotforsale": false }, { "_id": "662cc89ca04af9164c2b11f2", "fptag": "STERISHEALTHCAREPVTLTDD1C2", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRIGLICLAGLAZE 30 ", "description": "TRIGLICLAGLAZE 30 \nGliclazide (SR) Pioglitazone and Metformin HCL (SR)\nIntroduction\nThe treatment of Type 2 diabetes demands a comprehensive approach to effectively manage blood glucose levels and prevent long-term complications. TRIGLICLAGLAZE 30 offers a potent combination of Gliclazide (SR), Pioglitazone, and Metformin HCL (SR), providing a multifaceted strategy to tackle various aspects of diabetes management. This article explores the synergistic effects of these medications, their benefits, and the importance of such combination therapies in controlling Type 2 diabetes.\n\nUnderstanding the Components\nGliclazide (SR)\nGliclazide, a sulfonylurea, functions primarily by stimulating the release of insulin from the pancreatic beta cells. It is particularly effective in controlling blood sugar spikes after meals. The sustained release (SR) form of Gliclazide ensures a more gradual release of the medication, which helps in maintaining consistent blood sugar levels throughout the day, while minimizing the risk of hypoglycemia.\n\nPioglitazone\nPioglitazone is a thiazolidinedione that enhances insulin sensitivity in peripheral tissues, such as muscle and fat, and slightly inhibits hepatic gluconeogenesis. This action helps lower insulin resistance, which is a common issue in Type 2 diabetes. Pioglitazone also has benefits for lipid profiles, potentially reducing the risk of cardiovascular complications.\n\nMetformin HCL (SR)\nMetformin, the most commonly prescribed medication for Type 2 diabetes, works by reducing hepatic glucose production and improving insulin sensitivity. The sustained release (SR) formulation provides better gastrointestinal tolerability and a steadier absorption rate, which helps in managing fasting blood glucose levels more effectively.\n\nSynergistic Benefits for Diabetes Management\nComprehensive Glycemic Control\nThe combination of Gliclazide, Pioglitazone, and Metformin in TRIGLICLAGLAZE 30 targets multiple pathways involved in glucose metabolism. Gliclazide addresses postprandial glucose peaks, Pioglitazone improves insulin sensitivity, and Metformin stabilizes basal glucose levels. This comprehensive action helps achieve better overall glycemic control, reducing the risks associated with fluctuating blood sugar levels.\n\nReduced Risk of Hypoglycemia\nWhile Gliclazide could potentially cause hypoglycemia if taken alone, the risk is mitigated by the combination with Metformin and Pioglitazone—both of which do not typically cause low blood sugar levels. This balance provides effective glycemic control without the common side effects associated with high insulin levels.\n\nImproved Insulin Sensitivity and Metabolic Health\nPioglitazone not only assists in reducing blood glucose levels but also helps in improving lipid metabolism and reducing systemic inflammation, which are beneficial for overall metabolic health. The combined effect of these medications can also lead to improvements in weight management, particularly with the inclusion of Metformin.\n\nIdeal Candidates for TRIGLICLAGLAZE 30\nTRIGLICLAGLAZE 30 is suitable for patients with Type 2 diabetes who:\n\nRequire comprehensive management of their blood glucose levels.\nHave not achieved desired control with monotherapy or dual therapy.\nMay benefit from a combination that reduces the risk of cardiovascular diseases.\nDosage and Administration\nThe appropriate dosage of TRIGLICLAGLAZE 30 should be determined by a healthcare provider based on individual patient needs and existing conditions. It is typically taken once daily, which can aid in improving medication adherence due to the convenience of fewer daily doses.\n\nPotential Side Effects and Monitoring\nPatients on TRIGLICLAGLAZE 30 should be monitored for potential side effects, including:\n\nGastrointestinal issues from Metformin, although reduced by the SR formulation.\nWeight gain and fluid retention from Pioglitazone.\nHypoglycemia risk from Gliclazide, though less frequent with the SR formulation.\nRegular monitoring of liver and kidney function is also recommended due to the metabolic pathways affected by these drugs.\nFor further information: \n EMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668 \nhttps://www.sterisonline.com/product/trigliclaglaze-30-134278", "price": 125.0, "discountamount": 37.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "day", "fat", "meals", "risks", "EMAIL", "drugs", "liver", "muscle", "balance", "article", "patients", "SR) form", "inclusion", "treatment", "importance", "Components", "Gliclazide", "information", "medications", "monotherapy", "Weight gain", "convenience", "improvements", "sterisonline", "dual therapy", "common issue", "sterispharma", "sulfonylurea", "Introduction", "Pioglitazone", "Reduced Risk", "CALL/WHATSAPP", "Metformin HCL", "lipid profiles", "Administration", "SR formulation", "TRIGLICLAGLAZE", "gradual release", "various aspects", "Type 2 diabetes", "combined effect", "kidney function", "fluid retention", "lipid metabolism", "Ideal Candidates", "weight management", "fewer daily doses", "Hypoglycemia risk", "sustained release", "thiazolidinedione", "multiple pathways", "peripheral tissues", "blood sugar spikes", "appropriate dosage", "Regular monitoring", "potent combination", "glucose metabolism", "insulin resistance", "metabolic pathways", "synergistic effects", "existing conditions", "diabetes management", "healthcare provider", "insulin sensitivity", "high insulin levels", "common side effects", "basal glucose levels", "blood glucose levels", "medication adherence", "comprehensive action", "Synergistic Benefits", "systemic inflammation", "pancreatic beta cells", "multifaceted strategy", "combination therapies", "Potential Side Effects", "low blood sugar levels", "comprehensive approach", "Gastrointestinal issues", "long-term complications", "hepatic gluconeogenesis", "cardiovascular diseases", "comprehensive management", "overall metabolic health", "overall glycemic control", "individual patient needs", "steadier absorption rate", "hepatic glucose production", "effective glycemic control", "postprandial glucose peaks", "cardiovascular complications", "gastrointestinal tolerability", "consistent blood sugar levels", "Comprehensive Glycemic Control", "fluctuating blood sugar levels" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 875, "imageuri": "https://bizimages.withfloats.com/actual/9ccf82bc95ff4d2db8ead3ed82734379.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/9ccf82bc95ff4d2db8ead3ed82734379.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-27T09:42:52.128Z", "updatedon": "2024-04-27T09:42:52.128Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/indore/medicines/trigliclaglaze-30-/875", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Gliclazide (SR) Pioglitazone and Metformin HCL (SR)", "category": "Diabetic Range", "tags": [ "Glycinorm Total", "Triclazone", "Dianorm Total", "Tricyblex", "Glizid Total P", "Reclimet-PG", "Triglic", "Glz Total", "Bytey Total", "Carryl MP" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 0.0, "isnotforsale": false }, { "_id": "662b9520f590fc18c42c117c", "fptag": "STERISHEALTHCAREPVTLTDD1C2", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SEIZMET G2 FORTE ", "description": "SEIZMET G2 FORTE \nGlimepiride (2mg), Metformin (1000mg)\nIntroduction:\nDiabetes mellitus is a complex metabolic disorder that requires careful management to prevent complications and improve quality of life. Combining medications with complementary mechanisms of action is often necessary to achieve optimal glycemic control. SEIZMET G2 FORTE, a fixed-dose combination tablet containing glimepiride (2mg) and metformin (1000mg), offers a comprehensive approach to diabetes management. This article explores the features, efficacy, safety profile, and clinical implications of SEIZMET G2 FORTE in the treatment of type 2 diabetes mellitus (T2DM).\n\nUnderstanding Glimepiride and Metformin:\nGlimepiride is a sulfonylurea antidiabetic agent that stimulates insulin release from pancreatic beta cells, thereby lowering blood glucose levels. Metformin, on the other hand, is a biguanide medication that primarily reduces hepatic glucose production, enhances peripheral glucose uptake, and improves insulin sensitivity. By combining glimepiride and metformin, SEIZMET G2 FORTE addresses both insulin secretion and insulin resistance, providing comprehensive glycemic control.\n\nKey Features of SEIZMET G2 FORTE:\nSEIZMET G2 FORTE is a fixed-dose combination tablet containing glimepiride (2mg) and metformin (1000mg) in a standardized formulation. This combination offers the convenience of administering two effective antidiabetic agents in a single tablet, simplifying medication regimens and enhancing patient adherence. The combination of glimepiride and metformin allows for synergistic effects, resulting in better control of both fasting and postprandial hyperglycemia.\n\nEfficacy in Glycemic Control:\nClinical studies have demonstrated the efficacy of SEIZMET G2 FORTE in improving glycemic control in patients with T2DM. The combination of glimepiride and metformin has been shown to reduce hemoglobin A1c (HbA1c) levels, fasting plasma glucose, and postprandial glucose excursions, leading to improvements in overall glucose regulation. Additionally, the complementary mechanisms of action of glimepiride and metformin provide additive benefits in controlling blood sugar levels throughout the day.\n\nSafety Profile:\nSEIZMET G2 FORTE exhibits a favorable safety profile, with adverse effects typically mild to moderate in severity. Common side effects may include gastrointestinal symptoms such as nausea, diarrhea, or abdominal discomfort, which are often transient and diminish with continued use. Additionally, glimepiride may increase the risk of hypoglycemia, especially in elderly patients or those with renal impairment. However, when used judiciously, SEIZMET G2 FORTE is generally well-tolerated by most patients.\nFor further information: \n EMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668 \nhttps://www.sterisonline.com/product/seizmet-g2-forte-133439", "price": 158.0, "discountamount": 47.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "day", "risk", "life", "T2DM", "EMAIL", "action", "nausea", "quality", "article", "fasting", "severity", "diarrhea", "efficacy", "Metformin", "treatment", "other hand", "convenience", "information", "medications", "Glimepiride", "sterisonline", "improvements", "hypoglycemia", "sterispharma", "Key Features", "Introduction", "most patients", "CALL/WHATSAPP", "HbA1c) levels", "complications", "single tablet", "continued use", "hemoglobin A1c", "plasma glucose", "adverse effects", "insulin release", "elderly patients", "renal impairment", "SEIZMET G2 FORTE", "Clinical studies", "patient adherence", "additive benefits", "insulin secretion", "blood sugar levels", "insulin resistance", "careful management", "medication regimens", "insulin sensitivity", "Common side effects", "synergistic effects", "diabetes management", "abdominal discomfort", "biguanide medication", "blood glucose levels", "pancreatic beta cells", "clinical implications", "comprehensive approach", "favorable safety profile", "optimal glycemic control", "type 2 diabetes mellitus", "complementary mechanisms", "standardized formulation", "gastrointestinal symptoms", "peripheral glucose uptake", "complex metabolic disorder", "overall glucose regulation", "hepatic glucose production", "postprandial hyperglycemia", "fixed-dose combination tablet", "comprehensive glycemic control", "sulfonylurea antidiabetic agent", "postprandial glucose excursions", "two effective antidiabetic agents" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 868, "imageuri": "https://bizimages.withfloats.com/actual/8297066fb1af490e82ab625e7d210cf6.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/8297066fb1af490e82ab625e7d210cf6.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-26T11:50:56.715Z", "updatedon": "2024-04-26T11:50:56.715Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/indore/medicines/seizmet-g2-forte-/868", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Glimepiride (2mg), Metformin (1000mg)", "category": "Diabetic Range", "tags": [ "Glycomet-GP", "Gluconorm-G", "Gemer", "Glimestar-M", "Azulix MF", "Glimisave M", "Glucoryl-M", "Geminor M", "Diapride M", "Glimy M" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 0.0, "isnotforsale": false }, { "_id": "662b5f0bf7fe09029cbf4984", "fptag": "STERISHEALTHCAREPVTLTDD1C2", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LINALIGLIP 2.5 ", "description": "LINALIGLIP 2.5 \nLinagliptin 2.5 mg\nIntroduction:\nIn the realm of diabetes management, the advent of novel medications has revolutionized treatment approaches, offering patients more options to effectively manage their condition and improve their quality of life. Linagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, has emerged as a prominent player in this landscape. In particular, the formulation known as LINALIGLIP 2.5, featuring Linagliptin 2.5 mg, is gaining attention for its efficacy and safety profile. This article delves into the significance of LINALIGLIP 2.5 in the management of diabetes mellitus.\n\nUnderstanding Linagliptin:\nLinagliptin belongs to the class of medications known as DPP-4 inhibitors, which work by enhancing the levels of incretin hormones, such as glucagon-like peptide-1 (GLP-1), thereby increasing insulin secretion and decreasing glucagon levels. These actions help regulate blood sugar levels, making Linagliptin an invaluable tool in the management of type 2 diabetes mellitus (T2DM).\n\nKey Features of LINALIGLIP 2.5:\nLINALIGLIP 2.5 is a pharmaceutical formulation of Linagliptin, standardized to contain 2.5 mg of the active ingredient per dose. This dosage strength offers clinicians and patients flexibility in tailoring treatment regimens to individual needs, ensuring optimal glycemic control while minimizing the risk of adverse effects.\n\nEfficacy in Glycemic Control:\nClinical studies have demonstrated the efficacy of Linagliptin, including LINALIGLIP 2.5, in lowering hemoglobin A1c (HbA1c) levels, a key marker of long-term glucose control. By inhibiting DPP-4 activity, Linagliptin helps regulate postprandial glucose levels without increasing the risk of hypoglycemia, making it a valuable adjunct to existing antidiabetic therapies.\n\nSafety Profile:\nOne of the notable advantages of Linagliptin, including LINALIGLIP 2.5, is its favorable safety profile. Unlike some other antidiabetic medications, Linagliptin is not associated with weight gain or an increased risk of hypoglycemia, making it suitable for a wide range of patients, including those who are overweight or at risk of low blood sugar episodes.\n\nConvenience and Compliance:\nThe availability of LINALIGLIP 2.5 in a convenient oral formulation enhances patient compliance with treatment regimens. The once-daily dosing schedule simplifies medication management and fosters adherence, crucial factors in achieving optimal glycemic control and reducing the risk of diabetes-related complications.\n\nCombination Therapy:\nLINALIGLIP 2.5 can be used as monotherapy or in combination with other antidiabetic agents, such as metformin or sulfonylureas, to achieve synergistic effects in glycemic control. Its compatibility with various treatment modalities underscores its versatility in individualized diabetes management strategies.\nFor further information: \n EMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668 \n BUY NOW\nhttps://www.sterisonline.com/product/linaliglip-2-5-134280\n\n", "price": 205.0, "discountamount": 61.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "BUY", "GLP", "T2DM", "life", "risk", "dose", "EMAIL", "class", "realm", "advent", "product", "article", "quality", "actions", "options", "patients", "efficacy", "adherence", "landscape", "attention", "metformin", "peptide-1", "condition", "increased", "LINALIGLIP", "wide range", "key marker", "clinicians", "Convenience", "monotherapy", "flexibility", "information", "weight gain", "versatility", "availability", "Introduction", "Key Features", "sterisonline", "significance", "hypoglycemia", "sterispharma", "compatibility", "sulfonylureas", "CALL/WHATSAPP", "HbA1c) levels", "DPP-4 activity", "hemoglobin A1c", "crucial factors", "dosing schedule", "invaluable tool", "adverse effects", "dosage strength", "glucagon levels", "DPP-4 inhibitors", "DPP-4) inhibitor", "prominent player", "Clinical studies", "individual needs", "incretin hormones", "insulin secretion", "novel medications", "active ingredient", "treatment regimens", "Linagliptin 2.5 mg", "patient compliance", "notable advantages", "blood sugar levels", "synergistic effects", "Combination Therapy", "treatment approaches", "medication management", "dipeptidyl peptidase-4", "optimal glycemic control", "type 2 diabetes mellitus", "low blood sugar episodes", "favorable safety profile", "long-term glucose control", "other antidiabetic agents", "pharmaceutical formulation", "postprandial glucose levels", "convenient oral formulation", "various treatment modalities", "other antidiabetic medications", "diabetes-related complications", "existing antidiabetic therapies", "individualized diabetes management strategies" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 855, "imageuri": "https://bizimages.withfloats.com/actual/0cddf15cbc19437985a89dea1b69e262.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/0cddf15cbc19437985a89dea1b69e262.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-26T08:00:11.14Z", "updatedon": "2024-04-26T08:00:11.14Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/indore/medicines/linaliglip-2-5-/855", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Linagliptin 2.5 mg", "category": "Diabetic Range", "tags": [ "Trajenta", "Ondero", "Linanext", "Linatab", "Linalent", "Dynaglipt L", "Lincreta", "Linasmart", "Glylina" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 0.0, "isnotforsale": false }, { "_id": "65d8083fb156001d0c7653e7", "fptag": "STERISHEALTHCAREPVTLTDD1C2", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Amipulside 100", "description": "Amipulside 100\nAmisulpride \nAmipulside 100 is an antipsychotic medication used primarily in the treatment of schizophrenia and other psychotic disorders. It belongs to a class of medications known as second-generation antipsychotics.\nAmipulside 100 works by blocking the effects of dopamine, a neurotransmitter in the brain that is involved in regulating mood, behavior, and perception. By blocking dopamine receptors, amisulpride helps to reduce the symptoms of psychosis, such as hallucinations, delusions, and disorganized thinking.\nIn addition to its antipsychotic effects, Amipulside 100 has also been found to have antidepressant properties, particularly at lower doses. It is sometimes prescribed off-label for the treatment of depression, especially in individuals who have not responded to other antidepressant medications.\nAmipulside 100 is available in various formulations, including tablets and oral solutions, and the dosage prescribed depends on the individual's condition, response to treatment, and other factors. It's important for individuals taking amisulpride to follow their healthcare provider's instructions carefully and to attend regular follow-up appointments to monitor their progress and adjust treatment as needed.\nFor further information please contact:\ninfo@sterispharma.com / contact@sterispharma.com\ncall/whatsapp: 8209542042, 8955945010, 6377716668\nOrder Now - https://www.sterisonline.com/product/amipulside-100-133533", "price": 124.0, "discountamount": 38.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "mood", "brain", "label", "class", "dosage", "tablets", "product", "symptoms", "addition", "behavior", "progress", "response", "delusions", "psychosis", "treatment", "condition", "Amipulside", "depression", "perception", "individuals", "information", "lower doses", "Amisulpride", "instructions", "sterispharma", "sterisonline", "other factors", "schizophrenia", "oral solutions", "hallucinations", "neurotransmitter", "dopamine receptors", "healthcare provider", "various formulations", "disorganized thinking", "antipsychotic effects", "antipsychotic medication", "antidepressant properties", "other psychotic disorders", "regular follow-up appointments", "other antidepressant medications", "second-generation antipsychotics" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 825, "imageuri": "https://bizimages.withfloats.com/actual/6053ac485231480a92e5a0d811668e9a.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/6053ac485231480a92e5a0d811668e9a.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-02-23T02:51:43.648Z", "updatedon": "2024-06-24T05:14:41Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/indore/medicines/amipulside-100/825", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Amisulpride ", "category": "Neurology ", "tags": [ "amisulpride side effects", "amisulpride uses", "amisulpride dosage", "amisulpride maximum dose", "Amipulside 100 mg", "amisulpride injection", "amisulpride injection 5mg/2ml" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 12.0, "isnotforsale": false }, { "_id": "65d7c753058d611538322310", "fptag": "STERISHEALTHCAREPVTLTDD1C2", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ST- Gliptin M 50/500", "description": "ST- Gliptin M 50/500\nSitagliptin phosphate and metformin \nST- Gliptin M 50/500 are two different medications commonly used in the management of type 2 diabetes. They are often prescribed in combination to help control blood sugar levels effectively. Let's take a closer look at each of these medications:\nSitagliptin is the active ingredient in medications like Januvia and is classified as a dipeptidyl peptidase-4 (DPP-4) inhibitor.\nIt works by inhibiting the enzyme DPP-4, which breaks down incretin hormones like GLP-1 (glucagon-like peptide-1). Incretin hormones play a role in regulating blood sugar levels by stimulating insulin release and decreasing glucagon production, both of which lower blood sugar.\nSitagliptin helps increase the levels of these incretin hormones in the body, leading to improved blood glucose control, especially after meals.\nIt is typically taken as an oral tablet once daily.\nMetformin is one of the most commonly prescribed medications for type 2 diabetes.\nIt belongs to the class of drugs called biguanides.\nMetformin primarily works by reducing the production of glucose by the liver and increasing the sensitivity of muscle cells to insulin, allowing better glucose uptake from the bloodstream.\nAdditionally, metformin may help with weight management and can improve lipid profiles.\nIt is typically taken as an oral tablet and is available in both immediate-release and extended-release formulations.\nThe combination of ST- Gliptin M 50/500 is often prescribed to individuals with type 2 diabetes when metformin alone is insufficient to control blood sugar levels.\nThis combination offers complementary mechanisms of action: metformin primarily targets insulin resistance and liver glucose production, while sitagliptin enhances the effects of incretin hormones.\nBy using these two medications together, better glycemic control can be achieved.\n For further information please contact:\n info@sterispharma.com / contact@sterispharma.com\ncall/whatsapp: 8209542042, 8955945010, 6377716668, 7976417364\norder now: - https://www.sterisonline.com/product/st-gliptin-m-50-500-134013", "price": 415.0, "discountamount": 125.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "body", "role", "order", "meals", "class", "drugs", "GLP-1", "action", "enzyme", "Januvia", "effects", "metformin", "peptide-1", "combination", "individuals", "information", "oral tablet", "bloodstream", "sensitivity", "closer look", "sterisonline", "muscle cells", "sterispharma", "ST- Gliptin M", "glucose uptake", "lipid profiles", "insulin release", "type 2 diabetes", "two medications", "glycemic control", "DPP-4) inhibitor", "immediate-release", "weight management", "incretin hormones", "active ingredient", "insulin resistance", "blood sugar levels", "glucagon production", "blood glucose control", "Sitagliptin phosphate", "dipeptidyl peptidase-4", "complementary mechanisms", "liver glucose production", "two different medications", "extended-release formulations" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 742, "imageuri": "https://bizimages.withfloats.com/actual/cebb6c55e0ec4791ba7af0941fb6d72a.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/cebb6c55e0ec4791ba7af0941fb6d72a.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-02-22T22:14:43.191Z", "updatedon": "2024-06-18T11:29:19Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/indore/medicines/st-gliptin-m-50-500/742", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Sitagliptin phosphate and metformin ", "category": "Diabetic Range", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 12.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 10, "query": null, "floatingpoint": null }